MUST READS

Must Listen: A May 30, 2016 Here and Now WBUR.org radio segmenthighlighted the impact of caregiving on the health of caregivers. 

A May 30, 2016 MedicalXpress.com article reported that “At the Congress of the European Academy of Neurology in Copenhagen, Prof Gunhild Waldemar issued an appeal for researchers to work together and draw up standardised guidelines for early identification and treatment of the disease.” According to Gunhild, “European science could play a leading role, providing that it adopts a concerted approach and sufficient funds are made available. While research is expensive, standing by helplessly is even more so.” 

A May 30, 2016 The Washington Post article highlight tips on ways to talk to someone with Alzheimer’s. According to the article, “It is natural to want to pull back when someone seems to not recognize you or be confused in other ways, Drew says. But it is important to remember that the person with Alzheimer’s (and their caregivers) often feel isolated, lonely and sometimes hurt that people they have been so close to begin to shy away.”

A May 30, 2016 Herald Times Reporter letter to the editor by Connie Thimmig called Alzheimer’s the “defining disease of baby boomers.” According to Thiamin, “As these baby boomers age, one in eight will develop Alzheimer’s — a devastating, costly, heartbreaking disease. Increasingly for these boomers, it will no longer be their grandparents and parents who have Alzheimer’s — it will be them…With the cooperation of the medical and research communities, we are at a tipping point. They have the ideas, the technology and the will, but need focused commitment from the federal government. We need transformative, cost-effective strategic solutions to tackle this national public health crisis.”

A May 28, 2016 PBS Newshour broadcast segment with Alzheimer’s researcher Rob Moir highlighted a new study that finds Alzheimer’s “may stem from the brain’s past attempts to fight off infections.”

RESEARCH, SCIENCE, AND TECHNOLOGY 

A May 26, 2016 Alzheimer’s News Today article reported that “Brazilian researchers have developed a nanoscale biosensor that can detect molecules linked to Alzheimer’s, as well as other neurodegenerative diseases, and certain cancers.”

A May 24, 2016 Alzheimer’s News Today article reported that “Boulder, Colorado-based Accera has completed enrollment for its Phase 3 NOURISH AD clinical trial of AC-1204 for the treatment of mild to moderate Alzheimer’s disease (AD).”